IMV Inc IMVIF

RE:RE:RE:RE:IMV 5 year plan

[qwerty22]

When Fred spoke he talked about searching this Q as if they hadn't yet found anything but what you say makes sense, they could already have a sniff of something that they are looking to firm up. Why get too far ahead of yourself and then have to backtrack?

It would be special if they had a path forward in both programs. The hit rate in oncology is so low.

Breakthorough wrote: In relation to ovarian, in the coming milestones of last corporate presentation a week ago, they announce an update related to a biomarker in ovarian during this Q1. I assume it is for a more positive reading of the results, it doesn't make sense to announce it if it is not...